Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: Correlation with peritumoural oedema and other clinicoradiological and histological characteristics

Neurosurgical Review

Volumn 26, Issue 3, 2003, Pages 221-228

  Aguiar, Paulo Henrique ^a,b   Tsanaclis, Ana Maria ^a   Tella, Oswaldo Inácio ^c   Plese, José Pindaro ^a  

^a Sao Paulo Medical School   (Brazil)

^b Federal University of Sao Paulo ^*  (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brain tumour; Immunohistochemistry; Meningiomas; MIB 1

Indexed keywords

MONOCLONAL ANTIBODY; PEROXIDASE; STREPTAVIDIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN EDEMA; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MICROWAVE RADIATION; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

EID: 0037480749     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-003-0261-1     Document Type: Article

References (76)

1. Aguiar PH, Tatagiba M, Samii M, Ostertag H (1993) Métodos de estudo do potencial proliferativo das neoplasias primárias do sistema nervoso central. Valor prognóstico e implicação terapêutica. Arq Bras Neurocirurg 12:207-222
2. Aguiar PH, Tatagiba M, Dankoweit-Timpe E, Mathies C, Samii M, Ostertag H (1995) Proliferative activity of acoustic neurilemomas without neurofibromatosis determined by monoclonal antibody MIB 1. Acta Neurochir (Wien) 134:35-39
3. Aguiar PH, Tatagiba M, Samii M, Dankoweit-Timpe E, Ostertag H (1995) The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis 2 (NF2) and unilateral vestibular schwannomas using the monoclonal antibody MIB 1. Acta Neurochir (Wien) 134:40-45
4. Antinheimo J, Haapasai, H, Haltia M, Tatagiba M, Thomas S, Brandis A, Sainio M, Carpen O, Samii M, Jääskeläinen J (1997) Proliferation potential and features in neurofibromatosis 2-associated and sporadic meningiomas. J Neurosurg 87:610-614
5. Assieti R, Butti G, Magrassi L, Danova M, Riccardi A, Gaetani P (1990) Cell-kinetic characteristics of human brain tumours. Oncology 47:344-351
6. Baserga R (1981) The cell cycle. N Engl J Med 304:453-459
7. Boeker DK, Stark HJ (1988) The proliferation rate of intracranial tumours as defined by the monoclonal antibody Ki-67. Application of the method to paraffin-embedded specimens. Neurosurg Rev 11:267-272
8. Bouillot P, Pellissier J-P, Devictor B, Graziani N, Bianco N, Grisoli F, Figarella-Branger D (1994) Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. Correlation with clinical and morphological data. J Neurosurg 81:765-773
9. Bradac GB, Ferzt R, Bender A, Schoener W (1986). Peritumoral oedema in meningiomas: a radiological and histological study. Neuroradiology 28:304-312
10. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H (1993). Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33:212-218
11. Breiman RS, Beck JW, Korobkin M, Glenny R, Akwari OE, Heaston DK, Moore AV, Ram PC (1982) Volume determinations using computed tomography. AJR 138:329-333
12. Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 10:611-617
13. Cattoretti G, Becker MHG, Key G, Duchrow M, Schlueter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363
14. Cobb MA, Husain M, Andersen BJ, Al-Mefty O (1996) Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma. J Neurosurg 84:85-90
15. Deckert M, Reifenberger G, Wechsler W (1989) Determination of the proliferative potential of human brain tumours using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 115:179-188
16. Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13-20
17. Gerdes J, Dallenbach F, Lennert K, Lemke H, Stein H (1984) Growth fractions in malignant non-Hodgkin's lymphoma (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol 2:365-371
18. Gerdes J, Lelle RJ, Pickartz H, Heindrich W, Schwarting R, Kurtsiefer L, Stauch G, Stein H (1991) Growth fractions in breast cancers determined in situ with the monoclonal antibody Ki-67. J Clin Pathol 39:977-980
19. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD (1991) Immunobiochemical and molecular biologic characterisation of the cell proliferation-associated nuclear antigen that is defined by the monoclonal antibody Ki-67. Am J Pathol 138:867-873
20. Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H (1987) Growth fraction in human brain tumours defined by the monoclonal antibody Ki-67. Acta Neuropathol 74:179-182
21. Gottschalk J, Goebel S, Jautzke G (1992) Influence of preoperative dexamethasone therapy on proliferating cell nuclear antigen (PCNA) expression in comparison to other parameters in meningiomas. Histol Histopathol 7:653-661
22. Hara A, Hirayama H, Sakai N, Yamada H, Tanaka T, Mori H (1991) Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours. Acta Neurochir (Wien) 109:37-41
23. Hoshino T, Wilson CB (1979) Cell kinetics analyses of human malignant brain tumours (gliomas). Cancer 44:956-962
24. Hoshino T (1984) A commentary on biology and growth kinetics of low-grade gliomas. J Neurosurg 61:895-900
25. Hoshino T, Nagashima T, Murovic JA, Wilson CB, Davis RL (1986) Proliferative potential of human meningiomas of the brain, A cell kinetic study with bromo deoxyuridine. Cancer 59:1466-1472
26. Ide M, Jimbo M, Kubo O, Yamamoto M, Takeyama E, Imanaga H (1994) Peritumoral brain oedema and cortical damage by meningioma. Acta Neurochir (Wien) 60 [Suppl]:369-372
27. Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O (1995) Growth rate of intracranial meningioma: tumour doubling time and proliferating cell nuclear antigen staining index. Neurol Med Chir (Tokyo) 35:289-293
28. Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O (1996) MIB-1 staining index and peritumoral brain oedema of meningiomas. Cancer 78:133-143
29. Inamura T, Nishio S, Takeshita I, Fujisawa S, Fukui M (1992) Peritumoural brain oedema in meningiomas: influence of vascular supply on its development. Neurosurgery 31:179-185
30. Ironside JW, Battersby RDE, Lawry J, Loomes RS, Day CA, Timperley WR (1987) DNA in meningiomas tissue and explant cell cultures. A flow cytometric study with clinicopathological correlates. J Neurosurg 68:588-594
31. Jääskeläinen J, Haltia M, Laasonen E, Wahlströem T, Valtonen S (1985) The growth rate of intracranial meningiomas and its correlation to histology: an analysis of 43 patients. Surg Neurol 24:165-172
32. Jääskeläinen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242
33. Kallio M, Sankila R, Hakulinen T (1992) Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31:2-12
34. Karamitopolou E, Perentes E, Melachrinou M, Maraziotis T (1993) Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropathol 85:316-322
35. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T (1994) Ki-67 immunoreactivity in human central nervous system tumours: a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 87:47-54
36. Kaudewitz P, Braun-Falco O, Ernst M, Landhaler M, Stolz W, Gerdes J (1989) Tumour cell growth fractions in human malignant melanomas and the correlation to histopathologic tumour grading. Am J Pathol 134:1063-1068
37. Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the central nervous system. In: WHO (eds) International histological classification of tumours. Springer, Berlin, pp 33-42
38. Knosp E, Kitz K, Perneczcky A (1989) Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 25:927-930
39. Kunishio K, Ohmoto T, Matsushita T, Maeshiro T, Furuta T, Matsumoto K (1994) The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence. Cancer 73:2200-2205
40. Langford LA, Cooksley CS, De Monte F (1996) Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 27:350-354
41. Lellé RJ, Heindenreich W, Stauch G, Gerdes J (1987) The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma. Cancer 59:83-88
42. Lopez F, Belloc F, Lacombe F, Dumain P, Reiffers J, Bernard P, Boisseau MR (1994) The labelling of proliferating cells by Ki 67 and MIB-1 antibodies depends on the binding of a nuclear protein to DNA. Exp Cell Res 210:145-153
43. Maier H, Morimura T, Ofner D, Hallbrucker C, Kitz K, Budka H (1990) Argyrophilic nucleolar organizer region proteins (AgNORs) in human brain tumours: relations with grade of malignancy and proliferation indices. Acta Neuropathol 80:156-162
44. Maiuri F, Gangemi M, Cirillo S, Delehaye L, Gallicchio B, Carandente M, Giamundo A (1987) Cerebral oedema associated with meningiomas. Surg Neurol 127:64-68
45. Maiuri F, Montagnini S, Iaconetta G, Gallicchio B, Bernardo A, Signorelli F (1994) Correlation between sex hormone receptors and peritumoral oedema in intracranial meningiomas. J Neurosurg Sci 38:29-33
46. McCormick D, Chong H, Hobbs C, Datta C, Hall PA (1993) Detection of Ki-67 antigen in fixed and wax-embedded sections with monoclonal antibody MIB1. Histopathology 22:355-360
47. Miyagami M, Shibuya T, Miyagi A, Tsubokawa T (1996). Analysis of the proliferative potential of meningiomas with MIB-1 monoclonal antibodies. No To Shinkei 48:39-43
48. Morimura T, Kitz K, Budka H (1989) In situ analysis of cell kinetics in human brain tumours. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labelling technique, and of proliferating pool cells by monoclonal antibody Ki-67. Acta Neuropathol 77:276-282
49. Nagashima G, Aoyoagi M, Wakimoto H, Tamaki M, Ohno K, Hirakawa K (1995) Immunohistochemical detection of progesterone receptors and correlation with Ki-67 labeiling indices in paraffin-embedded sections of meningiomas. Neurosurgery 37:478-483
50. Nakabayashi H, Sakaguchi M, Katsuyama J, Hakuba A (1995) Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression. J Neurooncol 24:209-217
51. Nakasu S, Nakajima M, Matsumura K I, Nakasu Y, Handa J (1995) Meningioma: proliferating potential and clinicoradiological features. Neurosurgery 37:1049-1055
52. Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M (1994) MIB 1 staining index and scoring of histologic features in meningioma: indicators for the prediction of biologic potential and postoperative management. Cancer 74:3176-3189
53. Ostertag CB, Volk B, Shibata T, Burger P, Kleihues P (1987) The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours. Acta Neurochir (Wien) 89:117-121
54. Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou D (1988) Relationship between Ki-67 positive cells. Growth rate and histological type of human intracranial tumours. Anticancer Res 8:537-544
55. Plev PV, Hopf NJ, Knosp E, Goebel HH, Pemeczky A (1997) Proliferative activity of meningiomas: an immunohistological study using MIB-1 and anti -PCNA [abstract]. Skull Base Surg 7 [Suppl 1]:17
56. Prayson RA (1996) Malignant meningioma. A clinicopathologic study of 23 patients including MIB-land p53 immunohistochemistry. Am J Clin Pathol 105:719-726
57. Reifenberger G, Deckert M, Wechsler W (1989) Immunohistochemical determination of protein kinase c expression and proliferative activity in human brain tumours. Acta Neuropathol 78:166-175
58. Roggendorf W, Schuster T, Pfeiffer J (1987) Proliferative potential of meningiomas determined with monoclonal antibody Ki-67. Acta Neuropathol 73:361-364
59. Russel DS, Rubinstein LJ (1989) Pathology of tumours of the nervous system. In: Russel DS, Rubinstein LJ (eds) Williams and Wilkins, Baltimore, pp 452-453
60. Sano k, Hoshino T, Nagai M (1968) Radiosensitization of brain tumours cells with a thymidine analogue (bromouridine). J Neurosurg 28:530-538
61. Shi SR, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741-748
62. Shibuya M, Hoshino T, Ito S, Wacker MR, Prados MD, Davis RL, Wilson CB (1992) Meningiomas: clinical implications of high proliferative potential determined by bromodeoxyuridine labelling. Neurosurgery 30:494-498
63. Shibuya M, Satoyuki I, Miwa T, Davis R L, Wilson CB, Hoshino T (1993) Proliferative potential of brain tumours. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labelling, and nucleolar organizer region counts. Cancer 71:199-206
64. Shröder R, Bien K, Kott R, Meyers I, Vössing R (1991) The relationship between Ki-67 labelling and mitotic index in gliomas and meningiomas: demonstration of the variability of intermitotic cycle time. Acta Neuropathol 82:389-394
65. Siegers HP, Zuber P, Hamon MF, Van Melle GD, De Tribolet N (1989) The implications of heterogeneous distribution of Ki-67 labelled cells in meningiomas. Br J Neurosurg 3:101-108
66. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39
67. Smith HP, Challa VR, Moody DM, Kelly DL Jr (1981) Biological features of meningiomas that determine the production of cerebral oedema. Neurosurgery 8:428-433
68. Stevens JM, Ruiz JS, Kendall BE (1983) Observation on peritumoural oedema in meningioma. Part I: Distribution, spread and resolution of vasogenic oedema seen on computed tomography. Neuroradiology 25:71-80
69. Tatagiba M, Mirzai S, Samii M (1991) Peritumoral blood flow in intracranial meningiomas. Neurosurgery 28:400-404
70. Tsanaclis AM, Robert F, Michaud J, Brem S (1991) The cycling pool of cells within human brain tumours: in situ cytokinetics using the monoclonal antibody Ki-67. Can J Neurol Sci 18:12-17
71. Vassilouthis J, Ambrose J (1979) Computed tomography scanning appearances of intracranial meningiomas: an attempt to predict the histological features. J Neurosurg 50:320-327
72. Verheijein R, Kuijpers HJH, Schilingemann RO, Boehmer ALM, Van Driel R, Brakenhoff GJ, Ramaekers FCS (1989) Ki-67 detects a nuclear matrix-associated proliferation related antigen. I. Intracellular localisation during interphase. J Cell Sci 92:123-130
73. Verheijein R, Kuijpers HJH, Van Driel R, Beck JLM, Van Dierendonck JH, Brakenhoff GJ, Ramaekers FCS (1989) Ki-67 detects a nuclear matrix-associated proliferation related antigen. II. Localisation in mitotic cells and associated with chromosomes. J Cell Sci 92:531-540
74. Yasue M, Akasaki Y, Numoto TR, Abe S, Abe T, Takeuchi Y, Tanaka J (1996) MIB-1 immunostaining and DNA flow cytometry in Meningiomas. Noshyo Byori 13:17-20
75. Zorludemir S, Scheithauer BW, Hirose T, Van Houten C, Miller G, Meyer FB (1995) Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol 19:493-505
76. Zuber P, Hamou MF, Tribolet N (1988) Identification of proliferating cells in human gliomas using monoclonal antibody Ki-67. Neurosurgery 22:364-368